These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 7728215)

  • 21. Aging and Alzheimer's disease: protease inhibitors in cerebrospinal fluid.
    Delamarche C; Berger F; Gallard L; Pouplard-Barthelaix A
    Neurobiol Aging; 1991; 12(1):71-4. PubMed ID: 2002886
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Gene polymorphism affecting alpha1-antichymotrypsin and interleukin-1 plasma levels increases Alzheimer's disease risk.
    Licastro F; Pedrini S; Ferri C; Casadei V; Govoni M; Pession A; Sciacca FL; Veglia F; Annoni G; Bonafè M; Olivieri F; Franceschi C; Grimaldi LM
    Ann Neurol; 2000 Sep; 48(3):388-91. PubMed ID: 10976648
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prostaglandin E2 induced polymerization of human alpha-1-antichymotrypsin and suppressed its protease inhibitory activity: implications for Alzheimer's disease.
    Licastro F; Davis LJ; Pedrini S; Galasko D; Masliah E
    Biochem Biophys Res Commun; 1998 Aug; 249(1):182-6. PubMed ID: 9705853
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Alpha 1-antichymotrypsin level in cerebrospinal fluid is closely associated with late onset Alzheimer's disease.
    Harigaya Y; Shoji M; Nakamura T; Matsubara E; Hosoda K; Hirai S
    Intern Med; 1995 Jun; 34(6):481-4. PubMed ID: 7549128
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Combination of serum markers related to several mechanisms in Alzheimer's disease.
    Teunissen CE; Lütjohann D; von Bergmann K; Verhey F; Vreeling F; Wauters A; Bosmans E; Bosma H; van Boxtel MP; Maes M; Delanghe J; Blom HJ; Verbeek MM; Rieckmann P; De Bruijn C; Steinbusch HW; de Vente J
    Neurobiol Aging; 2003 Nov; 24(7):893-902. PubMed ID: 12928047
    [TBL] [Abstract][Full Text] [Related]  

  • 26. alpha 1-Antichymotrypsin as a risk modifier for late-onset Alzheimer's disease in Japanese apolipoprotein E epsilon 4 allele carriers.
    Yoshiiwa A; Kamino K; Yamamoto H; Kobayashi T; Imagawa M; Nonomura Y; Yoneda H; Sakai T; Nishiwaki Y; Sato N; Rakugi H; Miki T; Ogihara T
    Ann Neurol; 1997 Jul; 42(1):115-7. PubMed ID: 9225693
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Patterns of risk in first-degree relatives of patients with Alzheimer's disease.
    Silverman JM; Li G; Zaccario ML; Smith CJ; Schmeidler J; Mohs RC; Davis KL
    Arch Gen Psychiatry; 1994 Jul; 51(7):577-86. PubMed ID: 8031231
    [TBL] [Abstract][Full Text] [Related]  

  • 28. High brain myo-inositol levels in the predementia phase of Alzheimer's disease in adults with Down's syndrome: a 1H MRS study.
    Huang W; Alexander GE; Daly EM; Shetty HU; Krasuski JS; Rapoport SI; Schapiro MB
    Am J Psychiatry; 1999 Dec; 156(12):1879-86. PubMed ID: 10588400
    [TBL] [Abstract][Full Text] [Related]  

  • 29. No association between alpha 1-antichymotrypsin and familial Alzheimer's disease.
    Haines JL; Pritchard ML; Saunders AM; Schildkraut JM; Growdon JH; Gaskell PC; Farrer LA; Auerbach SA; Gusella JF; Locke PA; Rosi BL; Yamaoka L; Small GW; Conneally PM; Roses AD; Pericak-Vance M
    Ann N Y Acad Sci; 1996 Dec; 802():35-41. PubMed ID: 8993482
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Distinction between preclinical Alzheimer's disease and depression.
    Visser PJ; Verhey FR; Ponds RW; Kester A; Jolles J
    J Am Geriatr Soc; 2000 May; 48(5):479-84. PubMed ID: 10811539
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lack of genetic associations of alpha-1-antichymotrypsin polymorphism with alzheimer-type neuropathological changes or sporadic Alzheimer's disease.
    Sodeyama N; Yamada M; Itoh Y; Suematsu N; Matsushita M; Otomo E; Mizusawa H
    Dement Geriatr Cogn Disord; 1999; 10(3):221-5. PubMed ID: 10325450
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Association of elevated alpha 1-antichymotrypsin with cognitive impairment in a prospective study of the very old.
    Gabriel SM; Marin DB; Aisen PS; Lantz M; Altstiel LD; Davis KL; Mohs RC
    Am J Psychiatry; 1998 May; 155(5):698-700. PubMed ID: 9585727
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A case-control study of Alzheimer's disease in China.
    Li G; Shen YC; Li YT; Chen CH; Zhau YW; Silverman JM
    Neurology; 1992 Aug; 42(8):1481-8. PubMed ID: 1641140
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Relation of medial temporal lobe volumes to age and memory function in nondemented adults with Down's syndrome: implications for the prodromal phase of Alzheimer's disease.
    Krasuski JS; Alexander GE; Horwitz B; Rapoport SI; Schapiro MB
    Am J Psychiatry; 2002 Jan; 159(1):74-81. PubMed ID: 11772693
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The protease inhibitor, alpha 1-antichymotrypsin, is a component of the brain amyloid deposits in normal aging and Alzheimer's disease.
    Abraham CR; Potter H
    Ann Med; 1989; 21(2):77-81. PubMed ID: 2669847
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Alpha-1-antichymotrypsin immunoreactivity in papillary carcinoma of the thyroid gland.
    Lai ML; Rizzo N; Liguori C; Zucca G; Faa G
    Histopathology; 1998 Oct; 33(4):332-6. PubMed ID: 9822922
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Serum amyloid A protein, albumin and prealbumin in Alzheimer's disease and in demented patients with Down's syndrome.
    Elovaara I; Maury CP; Palo J
    Acta Neurol Scand; 1986 Sep; 74(3):245-50. PubMed ID: 2947417
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Physical disorders and causes of death in relatives of Alzheimer's disease patients.
    Kockler M; Nitardy A; Papassotiropoulos A; Ptok U; Maier W; Heun R
    Int J Geriatr Psychiatry; 2002 Apr; 17(4):335-42. PubMed ID: 11994887
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Plasma homocysteine in Alzheimer's disease with or without co-morbid depressive symptoms.
    Kitzlerová E; Fisar Z; Jirák R; Zvĕrová M; Hroudová J; Benaková H; Raboch J
    Neuro Endocrinol Lett; 2014; 35(1):42-9. PubMed ID: 24625917
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Alpha-1-antichymotrypsin (ACT or SERPINA3) polymorphism may affect age-at-onset and disease duration of Alzheimer's disease.
    Kamboh MI; Minster RL; Kenney M; Ozturk A; Desai PP; Kammerer CM; DeKosky ST
    Neurobiol Aging; 2006 Oct; 27(10):1435-9. PubMed ID: 16137793
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.